Caliway Biopharmaceuticals Co., Ltd.

TWSE:6919 Stock Report

Market Cap: NT$75.0b

Caliway Biopharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 6919?
Owner TypeNumber of SharesOwnership Percentage
Institutions49,7830.0357%
Public Companies4,800,0123.44%
Individual Insiders37,487,30426.9%
General Public97,081,68769.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.3%.


Top Shareholders

Top 9 shareholders own 30.37% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.9%
Yufang Ling
15,226,726NT$8.2b0%no data
7.71%
Kuihui Xu
10,751,498NT$5.8b0%no data
6.04%
Gaorong Zhang
8,420,020NT$4.5b0%no data
3.44%
Orient EuroPharma Co., Ltd.
4,800,012NT$2.6b0%no data
2.21%
Quan-Cheng Qiu
3,076,060NT$1.7b0%no data
0.03%
Exchange Traded Concepts, LLC
41,832NT$22.5m8.48%0.01%
0.0093%
Zhao-Jing Yuan
13,000NT$7.0m0%no data
0.0056%
Parametric Portfolio Associates LLC
7,877NT$4.2m0%no data
0.00005%
State Street Global Advisors, Inc.
74NT$37.5k0%no data